Upstream antibody processing
Upstream processing of promising cell lines to production readiness on hollow fiber reactors requires careful attention to detail.
But get it right and they offer unlimited quantities of cost-effective, consistent, homogenized antibody production. Perfect for research, assay development and downstream research, diagnostic and therapeutic uses.
Today, Inotiv delivers: Monoclonal and polyclonal antibody production; Hybridoma development; Immunogenicity immunization; Antibody purification; Mouse antibody production (MAP) testing.
History, strategies & challenges
Download the infographic series
Get the next infographic in the series, charting the history, production strategies and technology challenges faced when producing antibodies for research and manufacture. These resources provide insights collated from Inotiv’s long history in antibody production, with quick reference production strategies and useful reminders of the challenges commonly faced by researchers and production engineers.
